User profiles for J. M. Langley

Joanne Langley

Dalhousie University
Verified email at dal.ca
Cited by 12854

Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis

JM Langley, JC LeBlanc, J Drake… - Clinical infectious …, 1993 - academic.oup.com
The objective of this study was to determine if perioperative antimicrobial prophylaxis
decreases the incidence of subsequent shunt infection in patients who require placement of …

A decade of respiratory syncytial virus epidemiology and prophylaxis: translating evidence into everyday clinical practice

…, I Mitchell, A Banerji, KL Lanctôt, JM Langley - Canadian Respiratory …, 2011 - hindawi.com
… Dr Langley has received research funding from Abbott, MedImmune and Wyeth for RSV…
Hall CB, Douglas RG Jr, Geiman JM. Possible transmission by fomites of respiratory syncytial …

[HTML][HTML] Respiratory syncytial virus prefusion F protein vaccine in older adults

A Papi, MG Ison, JM Langley, DG Lee… - … England Journal of …, 2023 - Mass Medical Soc
Background Respiratory syncytial virus (RSV) is an important cause of acute respiratory
infection, lower respiratory tract disease, clinical complications, and death in older adults. There …

The impact of vaccination on coronavirus disease 2019 (COVID-19) outbreaks in the United States

…, LA Meyers, KM Neuzil, JM Langley… - Clinical Infectious …, 2021 - academic.oup.com
Background Global vaccine development efforts have been accelerated in response to the
devastating coronavirus disease 2019 (COVID-19) pandemic. We evaluated the impact of a 2-…

2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea

…, TS Steiner, K Kotloff, JM Langley… - Clinical Infectious …, 2017 - academic.oup.com
These guidelines are intended for use by healthcare professionals who care for children
and adults with suspected or confirmed infectious diarrhea. They are not intended to replace …

Nosocomial respiratory syncytial virus infection in Canadian pediatric hospitals: a Pediatric Investigators Collaborative Network on Infections in Canada Study

JM Langley, JC LeBlanc, EEL Wang, BJ Law… - …, 1997 - publications.aap.org
Objective. To determine nosocomial transmission of respiratory syncytial virus (RSV) in
Canadian pediatric hospitals, outcomes associated with nosocomial disease, and infection …

[HTML][HTML] Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in …

…, V Dzutseva, G Parveen, F Zhu, L Leppan, JM Langley… - The Lancet, 2022 - thelancet.com
Background The Ad5-nCoV vaccine is a single-dose adenovirus type 5 (Ad5) vectored vaccine
expressing the SARS-CoV-2 spike protein that was well-tolerated and immunogenic in …

Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial

…, DW Scheifele, TR Kollmann, SA Halperin, JM Langley… - Jama, 2013 - jamanetwork.com
Importance Global use of human papillomavirus (HPV) vaccines to prevent cervical cancer
is impeded by cost. A 2-dose schedule for girls may be possible. Objective To determine …

Safety and Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers

SA McNeil, SA Halperin, JM Langley… - Clinical Infectious …, 2005 - academic.oup.com
Background . Group A streptococcus (GAS) causes illness ranging from uncomplicated
pharyngitis to life-threatening necrotizing fasciitis, toxic shock, and rheumatic fever. Attempts to …

The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at …

BJ Law, JM Langley, U Allen, B Paes… - The Pediatric …, 2004 - journals.lww.com
Background: Infants born at 33 through 35 completed weeks of gestation (33-35GA) are at
risk for severe respiratory syncytial virus (RSV) infection, and palivizumab prophylaxis lowers …